Criticism of EU law is often aimed at an amorphous “Brussels,” but in many cases member states are the problem—as with the proposal to revise the Clinical Trials Directive. The […]
Jim Murray
Jim Murray: The EU, transparency, and access to clinical trial results
How is the EU involved in transparency and access to clinical trial results? Many readers will know this already, but perhaps not all. For obvious reasons, health professionals have tended […]
Jim Murray: The EMA’s efforts to widen access to clinical trial results
The European Medicines Agency is trying to widen access to clinical trial results for medicines that have been authorised. Its efforts have been blocked, at least temporarily, by a legal […]